Global Cardiac Marker Testing Market: Demand for More Accurate Diagnosis of Heart Disorder to Fuel Growth

The World Health Organization identifies cardiovascular diseases as one of the leading cause of death around the world. Nearly 17 million deaths due to heart problems are reported annually, compelling organizations and governments worldwide improve initiatives aimed at curbing the incidence. In a report, titled “Cardiac Marker Testing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024” Transparency Market Research (TMR) provides a comprehensive evaluation of the market, highlighting the factors that made cardiac marker testing one of the preferred methods for diagnosing health-related problems. The report covers growth drivers and restraints influencing the market’s trajectory between 2016 and 2024. It also segments it on the basis of various parameters for the purpose of the study.

Download a PDF Brochure of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18671

Cardiac markers are released into the blood when heart shows signs of irregularity. For instance, it is released when the heart is damaged or stressed. Cardiac markers include enzymes, proteins, and hormones. Measuring these biomarkers can help reveal significant data regarding heart health and diagnose various syndromes such as cardiac ischemia, coronary syndrome, and conditions generally associated with obstructed flow of blood to heart. Considering the vital statistics they provide regarding heart health, the demand for cardiac marker testing is scaling higher in response to the rising incidence of heart diseases.

Various factors are supporting the market’s expansion over the years, among these government funding and favorable initiatives by various organizations to boost clinical trials are at fore. On the downside, inadequate reimbursement schemes and unfavorable policies, especially across underdeveloped nations have continued posing threat to the global cardiac marker testing market. Also the diagnosis method is very time consuming, as determining cardiac markers level often take a long time. Growth will be hindered to an extent if market players continue to reel under the influence of these restraints.

Regionally, Asia Pacific, Latin America, Europe, North America, and the Middle East & Africa constitute the key market segments. Among these regions, North America showcases potentially the most lucrative opportunities for the market. The high incidence of cardiovascular diseases witnessed in North America, coupled with the presence of a sophisticated healthcare infrastructure enables strong growth in the cardiac marker testing market in the region. However, during the course of the report’s forecast period, rising geriatric population and increasing investment toward improving healthcare infrastructure will catapult Asia Pacific to the market’s fore. TMR expects Asia Pacific to showcase the leading CAGR during the forecast period.

Besides identifying the most lucrative pockets for the market, the report provides an in-depth analysis of its competitive landscape. It therefore includes profiles of companies such as Abbott Laboratories, Siemens Healthineers, LSI Medience Corporation, Bio-Rad Laboratories, Inc., Avantra Biosciences, Becton, Dickinson and Company, Helomics Corporation, Roche Diagnostics, Randox Laboratories Ltd., and Enzo Biochem. The operations of these companies and the effect of the same on the overall market performance is gauged in the report. This is intended at enabling stakeholders get an all-encompassing overview of the global cardiac marker testing market.

Read Report – http://www.transparencymarketresearch.com/cardiac-marker-testing-market.html

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 7996